Integrated Chinese and Western medicine telehealth for long-term diabetes care
Development of a New Integrated Strategy for Long-Distance and Full-Course Management of Diabetes Using Both Traditional Chinese and Western Medicine: A Combined Online and Offline Approach
This project will test an online platform that combines Traditional Chinese Medicine and Western medicine to manage adults with type 2 diabetes remotely.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Shanxi Bethune Hospital Academic / other |
| Locations | 1 site (Taiyuan, Shanxi) |
| Trial ID | NCT07265037 on ClinicalTrials.gov |
What this trial studies
The project builds an integrated online-offline diabetes management platform that combines TCM constitution differentiation with standard Western medical examinations and laboratory tests, using the pre-developed Idata database. It will create automated follow-up pathways and personalized care plans to support long-distance, full-course management with telemedicine components. Participants meeting standard diagnostic criteria for type 2 diabetes will be enrolled at Shanxi Bethune Hospital and followed through the platform, while patients with major comorbidities are excluded. The approach aims to reduce management costs and improve efficiency by automating routine follow-up and blending traditional and modern therapies.
Who should consider this trial
Good fit: Adults with type 2 diabetes who meet standard diagnostic glucose or HbA1c criteria, are able to use telemedicine tools, and do not have excluded severe comorbidities are ideal candidates.
Not a fit: People with active cancer, severe infections, multiple organ failure, major psychiatric disorders, rheumatic autoimmune diseases, or other conditions preventing protocol compliance are unlikely to benefit from this program.
Why it matters
Potential benefit: If successful, the program could offer low-cost, convenient, personalized long-distance diabetes care that lowers complication risk and reduces management burden.
How similar studies have performed: Telemedicine interventions have shown benefit for glycemic control in prior studies, while deeply integrated automated platforms combining TCM and Western medicine remain relatively novel and less well tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Presence of typical diabetes symptoms (polyuria, polydipsia, polyphagia, and unexplained weight loss) AND meeting any one of the following laboratory criteria: Fasting venous plasma glucose ≥ 7.0 mmol/L, or Random plasma glucose ≥ 11.1 mmol/L, or Glycated hemoglobin (HbA1c) ≥ 6.5%. * OR, meeting the following oral glucose tolerance test criteria:Fasting plasma glucose ≥ 7.0 mmol/L AND 2-hour plasma glucose ≥ 11.1 mmol/L after a 75g glucose load. Exclusion Criteria: * Comorbidities that may prevent compliance with the study protocol, including but not limited to: active malignancy, rheumatic autoimmune diseases, severe infections, multiple organ failure, or psychiatric disorders.
Where this trial is running
Taiyuan, Shanxi
- Shanxi Bethune Hospital — Taiyuan, Shanxi, China (Recruiting)
Study contacts
- Study coordinator: Shiwei Liu, Doctor
- Email: lswspring6@aliyun.com
- Phone: +86 13191072733
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.